The goal of this study was to measure the urinary isoprostane levels in patients with prostate cancer treated with radiotherapy ( RT ) in an effort to determine whether isoprostane levels are elevated compared with in historical controls , whether the levels increase after RT , and whether such an increase would correlate positively with the degree of GU symptoms during treatment .
